SCHEMBL29655194

SCHEMBL29655194

Nc1cc(-c2ccccc2C(F)(F)F)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.47
TDP1 Q9NUW8 3/20 0.46
TSHR P16473 1/20 0.46
AR P10275 1/20 0.44
MAPK1 P28482 1/20 0.43
EIF4E P06730 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
ALOX5AP P20292 1/20 0.42
FEN1 P39748 1/20 0.42
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
TRPA1 O75762 3/20 0.41
HSP90AA1 P07900 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
KIF11 P52732 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2311283 0.89 MAPT (0.58) BACE1TDP1TSHRAREIF4E
SCHEMBL29878607 0.83 MAPT (0.50) BACE1TDP1TSHRARMAPK1
SCHEMBL15522962 0.81 TDP1 (0.50) BACE1TDP1TSHRMAPK1EIF4E
SCHEMBL29655215 0.81 TDP1 (0.50) BACE1TDP1TSHRMAPK1EIF4E
SCHEMBL2313153 0.80 ALDH1A1 (0.44) BACE1TDP1ARMAPK1EIF4E
SCHEMBL11900334 0.78 BACE1 (0.56) BACE1TDP1TSHRARMAPK1
SCHEMBL29655141 0.78 BACE1 (0.56) BACE1TDP1TSHRARMAPK1
SCHEMBL2309293 0.78 CTSB (0.48) BACE1TDP1ARMAPK1EIF4E
SCHEMBL27542162 0.78 EIF4E (0.42) BACE1TDP1TSHRARMAPK1
SCHEMBL12844121 0.77 MAPT (0.47) TDP1AREIF4EMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed